OQROStart free trial
Politician trade (House)

Abbott Laboratories (ABT): Rep. Emily Randall (WA06) disclosed a sale $1K–$15K

Rep. Emily Randall (WA06) disclosed a sale of Abbott Laboratories in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
36 days
Disclosure lag
Traded
Jan 6, 2025
Disclosed
Feb 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 11, 2024CongressDisclosed partial sale of ABT — reported range $15,001 - $50,000
  2. Dec 16, 2024CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  3. Jan 6, 2025 · this disclosureCongressDisclosed sale of ABT — reported range $1,001 - $15,000

What came next

  1. Jan 8, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  2. Jan 15, 2025Congress · 1 personMembers of Congress: 3 sales
  3. Jan 28, 2025InsiderOfficer sold ~$337K of ABT shares in the open market
  4. Jan 28, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  5. Jan 29, 2025InsiderOfficer sold ~$16.9M of ABT shares in the open market
  6. Jan 29, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  7. Jan 30, 2025Insider · 2 peopleInsiders: 2 sales (~$10.5M)
  8. Feb 5, 2025InsiderCEO sold ~$37.4M of ABT shares in the open market
  9. Feb 13, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  10. Feb 15, 2025FDARecall: Aveir DR Leadless Pacemaker (LP) Ventricular Device REF LSP202V UDI-DI code: 05415067040725 REF LSP112V UDI-DI code: 05415067034472 The Aveir leadless pacemake…
  11. Feb 20, 2025FDAFDA device clearance: Alinity h-series System
  12. Feb 24, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  13. Mar 3, 2025Insider · 5 peopleInsiders: 5 sales (~$549K)
  14. Mar 3, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  15. Mar 6, 2025InsiderOfficer sold ~$12.2M of ABT shares in the open market
  16. Mar 6, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  17. Mar 7, 2025InsiderOfficer sold ~$27K of ABT shares in the open market
  18. Mar 17, 2025FDARecall: Amplatzer TorqVue LP Delivery System (TVLP), Model nos. 9-TVLP4F90/060 and 9-TVLP4F90/080
  19. Mar 17, 2025FDARecall: Amplatzer TorqVue LP Catheter (TVLPC), Model no. 9-TVLPC4F90/080
  20. Mar 18, 2025FDARecall: Brand Name: CELL-DYN Ruby Product Name: CELL-DYN Ruby Model/Catalog Number: 08H67-01 Software Version: All software versions Product Description: CELL-DYN Ruby…
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 6 Congress trade reports and 59 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Rep. Emily Randall (WA06)

The full history of Rep. Emily Randall (WA06) is on the profile page.

How this filing works

Explore the data

Other disclosures at Abbott Laboratories

Everything OQRO holds on this company is on its ABT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data